Attitudes regarding predictive testing for retinitis pigmentosa

Ophthalmic Genetics

Volumn 28, Issue 1, 2007, Pages 9-15

  Mezer, Eedy ^a   Babul Hirji, Riyana ^a   Wise, Richard ^b   Chipman, Mary ^a,b   Dasilva, Lisa ^a   Rowell, Mary ^a   Thackray, Robin ^c   Shuman, Cheryl T ^a   Levin, Alex V ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autosomal dominant retinitis pigmentosa; Predictive testing; Prenatal genetic testing; Presymptomatic genetic testing

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; EMOTIONAL STRESS; FEMALE; GENETIC COUNSELING; HUMAN; MALE; PEDIGREE ANALYSIS; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RETINITIS PIGMENTOSA; SIBLING; SOCIAL ASPECT;

ADULT; ATTITUDE TO HEALTH; FAMILY; FEMALE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETINITIS PIGMENTOSA;

EID: 34147092062     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.1080/13816810701199423     Document Type: Article

References (53)

1. Wang DY, Chan WM, Tam PO, Baum L, Lam DS, Chong KK, et al. Gene mutations in retinitis pigmentosa and their clinical implications. Clin Chim Acta. 2005;351(1-2):5-16.
2. American Society of Human Genetics Board of Directors & American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57(5):1233-1241.
3. Boughman JA, Caldwell RJ. Assessment of clinical variables and counseling needs in patients with retinitis pigmentosa. Am J Med Genet. 1982;12(2):185-193.
4. Greenberg J, Ramesar R, Beighton P. Genetic mapping of retinitis pigmentosa-implications for South African patients. S Afr Med J. 1994;84(7):410-412.
5. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl. 2002;80(233):1-34.
6. Kaplan J, Bonneau D, Frezal J, Munnich A, Dufier JL. Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet. 1990;85(6):635-642.
7. Iannaccone A, De Propris G, Roncati S, Rispoli E, Del Porto G, Pannarale MR. The ocular phenotype of the Bardet-Biedl syndrome. Comparison to non-syndromic retinitis pigmentosa. Ophthalmic Genet. 1997;18(1):13-26.
8. Fishman GA, Fishman M, Maggiano J. Macular lesions associated with retinitis pigmentosa. Arch Ophthalmol. 1977;95(5):798-803.
9. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2002;109(3):560-568.
10. RetNet: The Retinal Information Network. Houston. Stephen P. Daiger, Ph.D., and the University of Texas-Houston Health Science Center, c1996-2005 [updated 2005 July 18; cited 2005 August 21]. 2005.
11. Smith CO, Lipe HP, Bird TD. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol. 2004;61(6):875-880.
12. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet. 1994;31(10):785-797.
13. Robertson S, Savulescu J. Is there a case in favour of predictive genetic testing in young children? Bioethics. 2001;15(1):26-49.
14. Savulescu J. Predictive genetic testing in children. Med J Aust. 2001;175(7):379-381.
15. Steinbart EJ, Smith CO, Poorkaj P, Bird TD. Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol. 2001;58(11):1828-1831.
16. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky O, Trew M, et al. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet. 1992;42(4):508-515.
17. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M, et al. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med. 1992;327(20):1401-1405.
18. Ross LF, Moon MR. Ethical issues in genetic testing of children. Arch Pediatr Adolesc Med. 2000;154(9):873-879.
19. Fryer A. Inappropriate genetic testing of children. Arch Dis Child. 2000;83(4):283-285.
20. Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents. Who decides? J Am Med Assoc. 1994;272(11):875-881.
21. Taneja PR, Pandya A, Foley DL, Nicely LV, Arnos KS. Attitudes of deaf individuals towards genetic testing. Am J Med Genet A. 2004;130(1):17-21.
22. Fanos JH, Gelinas DF, Miller RG. 'You have shown me my end': attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet A. 2004;129(3):248-253.
23. Ross LF. Should children and adolescents undergo genetic testing? Pediatr Ann. 2004;33(11):762-769.
24. Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD, et al. Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A. 2003;116(2):117-128.
25. Jones I, Scourfield J, McCandless F, Craddock N. Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. J Affect Disord. 2002;71(1-3):189-193.
26. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Niermeijer MF. Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands. J Med Genet. 2000;37(11):883-884.
27. Malkin D, Australie K, Shuman C, Barrera M, Weksberg R. Parental attitudes to genetic counseling and predictive testing for childhood cancer. Am J Hum Genet. 1996;59(4):A7.
28. Denayer L, Evers-Kiebooms G, De Boeck K, Van den Berghe H. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis. Am J Med Genet. 1992;44(1):104-111.
29. Macnicol AM, Wright AF, Watson ML. Education and attitudes in families with adult polycystic kidney disease. Nephrol Dial Transplant. 1991;6(1):27-30.
30. Leung TY, Leung CM. Insight into the psychosocial aspects of Huntington's disease in Chinese society. Int J Psychiatry Med. 2002;32(3):305-310.
31. Kirkwood SC, Siemers E, Viken R, Hodes ME, Conneally PM, Christian JC, et al. Longitudinal personality changes among presymptomatic Huntington disease gene carriers. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15(3):192-197.
32. Burgess MM, Adam S, Bloch M, Hayden MR. Dilemmas of anonymous predictive testing for Huntington disease: privacy vs. optimal care. Am J Med Genet. 1997;71(2):197-201.
33. Almqvist E, Adam S, Bloch M, Fuller A, Welch P, Eisenberg D, et al. Risk reversals in predictive testing for Huntington disease. Am J Hum Genet. 1997;61(4):945-952.
34. Kessler S. Predictive testing for Huntington disease: a psychologist's view. Am J Med Genet. 1994;54(3):161-166.
35. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet. 1994;54(3):167-173.
36. Benjamin CM, Adam S, Wiggins S, Theilmann JL, Copley TT, Bloch M, et al. Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet. 1994;55(4):606-617.
37. Bloch M, Adam S, Fuller A, Kremer B, Welch JP, Wiggins S, et al. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet. 1993;47(3):368-374.
38. Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, et al. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. J Am Med Assoc. 1993;270(19):2321-2325.
39. Bloch M, Hayden MR. Opinion: predictive testing for Huntington disease in childhood: challenges and implications. Am J Hum Genet. 1990;46(1):1-4.
40. Kessler S, Field T, Worth L, Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987;26(2):259-270.
41. Markel DS, Young AB, Penney JB. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet. 1987;26(2):295-305.
42. Mastromauro C, Myers RH, Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet. 1987;26(2):271-282.
43. Tyler A, Ball D, Craufurd D. Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium. Br Med J. 1992;304(6842):1593-1596.
44. Heon E. Predictive DNA testing in ophthalmology: view 1. Br J Ophthalmol. 2003;87(5):633-635.
45. Mackey DA, Heon E, Webster AR. Predictive DNA testing in ophthalmology. Br J Ophthalmol. 2003;87(5):633.
46. Webster AR. Predictive DNA testing in ophthalmology: view 2. Br J Ophthalmol. 2003;87(5):635-636.
47. Mackey DA. Overview. Predictive DNA testing in ophthalmology. Br J Ophthalmol. 2003;87(5):637-638.
48. Furu T, Kaariainen H, Sankila EM, Norio R. Attitudes towards prenatal diagnosis and selective abortion among patients with retinitis pigmentosa or choroideremia as well as among their relatives. Clin Genet. 1993;43(3):160-165.
49. Pawlowitzki IH, Ruther K, Brunsmann F, von Gizycki R. Acceptability of prenatal diagnosis for retinitis pigmentosa. Lancet. 1986;2(8520):1394- 1395.
50. Malkin D, Friend SH. Screening for cancer susceptibility in children. Curr Opin Pediatr. 1994;6(1):46-51.
51. Hamann HA, Croyle RT, Venne VL, Baty BJ, Smith KR, Botkin JR. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. Am J Med Genet. 2000;92(1):25-32.
52. Umans-Eckenhausen MA, Oort FJ, Ferenschild KC, Defesche JC, Kastelein JJ, de Haes JC. Parental attitude towards genetic testing for familial hypercholesterolaemia in children. J Med Genet. 2002;39(9):e49.
53. Meryash DL, Abuelo D. Counseling needs and attitudes toward prenatal diagnosis and abortion in fragile-X families. Clin Genet. 1988;33(5):349-355.